Literature DB >> 31529177

Clinical characteristics in patients with rest angina and hypoplastic right coronary artery.

Shozo Sueda1, Hiroaki Kohno2.   

Abstract

Hypoplastic coronary artery disease is a rare congenital abnormality reported to be associated with myocardial infarction and sudden cardiac death. Provoked positive spasm in the left circumflex coronary artery (LCX) with pharmacological spasm provocation tests was remarkably lower than other coronary arteries. We sometimes encountered patients with rest angina and hypoplastic right coronary artery (H-RCA). Among 5953 patients with diagnostic and follow-up coronary arteriography, we found 93 patients (1.6%) with H-RCA. During the same period, we could perform spasm provocation tests in 564 patients with rest angina including 13 patients with H-RCA and 249 patients with effort angina including 10 patients with H-RCA. Pharmacological spasm provocation tests were performed in 51 of 93 patients including 34 patients with ischemic heart disease (IHD) and 17 patients with non-IHD. Provoked spasm incidence in patients with IHD was higher than in those with non-IHD but not significant (52.9% vs. 29.4%, p = 0.1114). Provoked positive spasm in the LCX in patients with rest angina and H-RCA was significantly higher than that in those without H-RCA (69.2% vs. 23.4%, p < 0.001). Provoked spasm on both left anterior descending artery and LCX in patients with rest angina and H-RCA was also remarkably higher than in those without H-RCA (53.8% vs. 3.1%, p < 0,001). There were no clinical differences between patients with and without H-RCA rest angina. Two-vessel spasm (61.5% vs. 0%, p < 0.01) and LCX-provoked spasm (69.2% vs. o%, p < 0.01) were significantly higher in patients with H-RCA and rest angina than that in those with H-RCA and effort angina. In patients with rest angina and H-RCA, LCX-positive spasm was significantly higher and these patients may have a potential of high disease activity in the clinic as a coronary spastic angina.

Entities:  

Keywords:  Acetylcholine; Ergonovine; Rest angina; Right coronary hypoplasty; Spasm provocation test

Mesh:

Substances:

Year:  2019        PMID: 31529177     DOI: 10.1007/s00380-019-01507-w

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  16 in total

1.  Major complications during spasm provocation tests with an intracoronary injection of acetylcholine.

Authors:  S Sueda; H Saeki; T Otani; K Mineoi; T Kondou; K Yano; T Ochi; N Ochi; Y Hayashi; T Tsuruoka; H Kawada; S Matsuda; T Uraoka
Journal:  Am J Cardiol       Date:  2000-02-01       Impact factor: 2.778

2.  Clinical characteristics and possible mechanism of paroxysmal atrial fibrillation induced by intracoronary injection of acetylcholine.

Authors:  S Sueda; H Fukuda; K Watanabe; N Ochi; H Kawada; Y Hayashi; T Uraoka
Journal:  Am J Cardiol       Date:  2001-09-01       Impact factor: 2.778

3.  Images in cardiovascular medicine. Myocardial infarction in children with hypoplastic coronary arteries.

Authors:  A Fraisse; J Quilici; I Canavy; B Savin; F Aubert; M Bory
Journal:  Circulation       Date:  2000-03-14       Impact factor: 29.690

4.  Hypoplastic coronary artery disease: A rare cause of sudden cardiac death and its treatment with an implantable defibrillator.

Authors:  Craig McFarland; Rajiv S Swamy; Atman Shah
Journal:  J Cardiol Cases       Date:  2011-09-14

5.  Differential incidence and type of spasm according to coronary arterial location.

Authors:  Shozo Sueda; Hiroaki Kohno
Journal:  Coron Artery Dis       Date:  2016-06       Impact factor: 1.439

6.  Frequency of provoked coronary vasospasm in patients undergoing coronary arteriography with spasm provocation test of acetylcholine.

Authors:  S Sueda; N Ochi; H Kawada; S Matsuda; Y Hayashi; T Tsuruoka; T Uraoka
Journal:  Am J Cardiol       Date:  1999-04-15       Impact factor: 2.778

7.  Hypoplastic coronary artery disease: report of one case.

Authors:  N Amabile; A Fraisse; J Quilici
Journal:  Heart       Date:  2005-02       Impact factor: 5.994

8.  Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations.

Authors:  Shozo Sueda; Hiroaki Kohno; Hiroshi Fukuda; Naoto Ochi; Hiroyuki Kawada; Yutaka Hayashi; Tadao Uraoka
Journal:  Coron Artery Dis       Date:  2004-12       Impact factor: 1.439

9.  Frequency of provoked coronary spasms in patients undergoing coronary arteriography using a spasm provocation test via intracoronary administration of ergonovine.

Authors:  Shozo Sueda; Hiroaki Kohno; Hiroshi Fukuda; Naoto Ochi; Hiroyuki Kawada; Yutaka Hayashi; Tadao Uraoka
Journal:  Angiology       Date:  2004 Jul-Aug       Impact factor: 3.619

10.  Impact of pharmacological spasm provocation test in patients with a history of syncope.

Authors:  Shozo Sueda; Hiroaki Kohno
Journal:  Heart Vessels       Date:  2017-09-13       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.